Trial Profile
A randomised clinical study comparing whole brain radiotherapy (WBRT) vs whole brain radiotherapy with concurrent temozolomide (TMZ) for brain metastasis from lung and breast primaries - NIL
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Brain metastases; Breast cancer; Lung cancer; Male breast cancer
- Focus Therapeutic Use
- 16 Aug 2013 New trial record